C1q Antibodies

Santa Cruz Biotechnology features a diverse variety of C1q monoclonal antibodies for advanced research in immunology and related fields. C1q monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C1q is a crucial component of the complement system, playing a significant role in the immune response by recognizing and binding to pathogens and apoptotic cells. C1q initiates the activation of the classical complement pathway, which aids in opsonization and clearance of immune complexes. Understanding C1q function is vital for elucidating mechanisms of autoimmune diseases and other immune-related disorders. C1q research has revealed important connections between complement activation and various inflammatory conditions. Investigating C1q interactions provides valuable information about immune system regulation and potential therapeutic targets. Recent studies have highlighted C1q's role in maintaining tissue homeostasis and preventing autoimmunity. Santa Cruz Biotechnology monoclonal antibodies for C1q support researchers worldwide in advancing our understanding of immune system function and developing new therapeutic approaches.